Table 2.
Ceftobiprole-resistant isolates from 17 countries in Europe
| Pathogen | Percentage of resistant isolates (n/N) across European regionsa | |||
|---|---|---|---|---|
| North | South | West | East | |
| MRSA | 0 (0/198) | 0.4 (7/1611) | 0.5 (5/997) | 1.0 (7/696) |
| S. pneumoniae | 0.5 (1/191) | 3.2 (29/897) | 1.5 (18/1212) | 2.5 (18/707) |
| Enterobacterales | 16.3 (127/779) | 27.4 (814/2971) | 19.9 (487/2442) | 27.6 (277/1005) |
| P. aeruginosa b | 29.0 (79/272) | 36.4 (299/822) | 29.7 (207/696) | 42.4 (170/401) |
| All isolatesb | 8.8 (164/1854) | 12.8 (976/7611) | 7.7 (532/6911) | 11.1 (401/3624) |
a
European regions: North = Denmark, Sweden, UK; West = Austria, Belgium, France, Germany, the Netherlands; East = Czech Republic, Hungary, Romania, Russia, Slovenia; South = Greece, Italy, Portugal, Spain.
b
PK/PD breakpoint was applied.